{"id":"https://openalex.org/W2980544849","doi":"https://doi.org/10.1182/blood-2018-99-117572","title":"Ixazomib in Previously Untreated Indolent B-Cell Non-Hodgkin Lymphoma","display_name":"Ixazomib in Previously Untreated Indolent B-Cell Non-Hodgkin Lymphoma","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2980544849","doi":"https://doi.org/10.1182/blood-2018-99-117572","mag":"2980544849"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-117572","doi":"https://doi.org/10.1182/blood-2018-99-117572","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-117572","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071690547","display_name":"Solomon A. Graf","orcid":"https://orcid.org/0000-0002-9475-3016","observed_orcids":["https://orcid.org/0000-0002-9475-3016"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Solomon A. Graf","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005281918","display_name":"Ryan C. Lynch","orcid":"https://orcid.org/0000-0001-6703-0894","observed_orcids":["https://orcid.org/0000-0001-6703-0894"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan C. Lynch","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004667245","display_name":"David Glen Coffey","orcid":"https://orcid.org/0000-0003-3544-8836","observed_orcids":["https://orcid.org/0000-0003-3544-8836"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Coffey","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296565","display_name":"Mazyar S. Shadman","orcid":"https://orcid.org/0000-0002-3365-6562","observed_orcids":["https://orcid.org/0000-0002-3365-6562"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazyar Shadman","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022775720","display_name":"Sandra Kanan","orcid":"https://orcid.org/0000-0003-0841-3558","observed_orcids":["https://orcid.org/0000-0003-0841-3558"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Kanan","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084492085","display_name":"Edward N. Libby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward N. Libby","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064080252","display_name":"Edus Houston Warren","orcid":"https://orcid.org/0000-0002-9570-2755","observed_orcids":["https://orcid.org/0000-0002-9570-2755"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edus H. Warren","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086034320","display_name":"Colin D. Godwin","orcid":"https://orcid.org/0000-0002-6564-9690","observed_orcids":["https://orcid.org/0000-0002-6564-9690"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin Godwin","raw_affiliation_strings":["Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949296","display_name":"Ted Alan Gooley","orcid":"https://orcid.org/0000-0002-8182-3652","observed_orcids":["https://orcid.org/0000-0002-8182-3652"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ted Gooley","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020858509","display_name":"Jonathan R. Fromm","orcid":"https://orcid.org/0000-0002-2287-5284","observed_orcids":["https://orcid.org/0000-0002-2287-5284"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan R. Fromm","raw_affiliation_strings":["Department of Laboratory Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020858509","https://openalex.org/A5023949296","https://openalex.org/A5071690547"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"5326","last_page":"5326"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/indolent-b-cell-non-hodgkin-lymphoma","display_name":"indolent B-cell non-Hodgkin lymphoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.6869999766349792},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7870000004768372},{"id":"https://openalex.org/keywords/oral-proteasome-inhibitor","display_name":"oral proteasome inhibitor","score":0.6589999794960022},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.7210000157356262},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5910000205039978},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4189999997615814},{"id":"https://openalex.org/keywords/flipi-risk-stratification","display_name":"FLIPI risk stratification","score":0.6100000143051147},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8364242315292358},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7077139019966125},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6656568050384521},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6527045965194702},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5766537189483643},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5753289461135864},{"id":"https://openalex.org/C2778563104","wikidata":"https://www.wikidata.org/wiki/Q18553449","display_name":"Marginal zone B-cell lymphoma","level":5,"score":0.4947054088115692},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4853166937828064},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.4823036193847656},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.440105676651001},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4387819170951843},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.42030495405197144},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35666918754577637},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3505750894546509},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3124130368232727},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.24994179606437683},{"id":"https://openalex.org/C2779921676","wikidata":"https://www.wikidata.org/wiki/Q6760434","display_name":"Marginal zone","level":4,"score":0.21901598572731018},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21478760242462158},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18770885467529297}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-117572","doi":"https://doi.org/10.1182/blood-2018-99-117572","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-117572","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3096624968","https://openalex.org/W2984553290","https://openalex.org/W4309147176","https://openalex.org/W3097836021","https://openalex.org/W4417009747","https://openalex.org/W4392586163","https://openalex.org/W2550942507","https://openalex.org/W2594820239","https://openalex.org/W2994214107","https://openalex.org/W2602729549"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Frontline":[2],"treatment":[3,94,268,377,507,574,599],"of":[4,29,58,127,176,185,241,277,317,334,413,441,508,524,528,568,571,573,585,595],"indolent":[5],"B-cell":[6],"non-Hodgkin":[7],"lymphoma":[8,211,218,225,233],"(iB-NHL)":[9],"typically":[10],"involves":[11],"intravenously":[12],"administered":[13,106],"anti-CD20":[14],"monoclonal":[15],"antibodies":[16],"with":[17,26,46,73,180,256,308,326,356,387,408,418,510,562,591],"or":[18,121,430,551],"without":[19,369],"cytotoxic":[20],"chemotherapy.":[21],"Effective":[22],"and":[23,40,99,124,160,173,203,230,248,280,294,347,362,374,380,457,465,501,518],"low-toxicity":[24],"therapies":[25],"improved":[27],"convenience":[28],"administration":[30],"are":[31,537,545,587],"sought.":[32],"We":[33],"hypothesized":[34],"that":[35,389,495],"ixazomib":[36],"(Ix)":[37],"could":[38],"safely":[39],"conveniently":[41],"induce":[42],"remissions":[43],"in":[44,60,80,252,471,476,504],"patients":[45,72,190,255,289,307,325,364,386,473,512,561],"untreated":[47,61,74],"iB-NHL.":[48,62,563],"Here":[49],"we":[50],"present":[51,251],"the":[52,134,138,239,265,301,312,427,439,442,505,522,592],"first":[53],"data":[54,443],"on":[55,96,114,349,376,540,600],"frontline":[56,506,557],"use":[57],"Ix":[59,104,335,496,550],"Methods:":[63],"This":[64],"single-arm,":[65],"open-label":[66],"phase":[67,315],"II":[68],"\"window\"":[69],"trial":[70],"for":[71,93,169,267,292,451,559,579],"iB-NHL":[75],"(NCT02339922)":[76],"opened":[77],"to":[78,201,272,283,516,533,547,576],"enrollment":[79],"May":[81],"2016.":[82],"Eligibility":[83],"included":[84,209,269,458],"histopathologically":[85],"confirmed":[86],"iB-NHL,":[87],"measurable":[88],"disease,":[89],"a":[90,112,342,409,424,555],"clinical":[91],"indication":[92,266],"based":[95],"NCCN":[97],"guidelines,":[98],"no":[100],"prior":[101],"systemic":[102],"treatment.":[103],"was":[105,145,167,196],"at":[107,156,438],"4":[108,324,345,360,381],"mg":[109],"orally":[110],"once":[111],"week":[113],"consecutive":[115],"28-day":[116],"cycles":[117,159,333,346,572],"until":[118],"disease":[119,247,273,278,284,358],"progression":[120,276,401],"unacceptable":[122],"toxicity":[123],"four":[125],"doses":[126,584],"weekly":[128,583],"rituximab":[129,586],"(R)":[130],"were":[131,191,205,250,290,454],"added":[132],"during":[133,300,426],"7th":[135,593],"cycle,":[136],"after":[137,149,344,359,435],"initial":[139],"window":[140,303,314,429],"period.":[141],"The":[142,193,445],"primary":[143],"endpoint":[144],"investigator-assessed":[146],"response":[147,293,372,433],"rate":[148],"independent":[150],"radiology":[151],"review.":[152],"Response":[153],"assessment":[154,434],"occurred":[155,470,484],"every":[157],"2":[158,363,379,475],"using":[161],"standard":[162],"(Lugano)":[163],"criteria.":[164],"Tumor":[165],"tissue":[166],"collected":[168],"gene":[170],"expression":[171],"profiling":[172],"immunohistochemical":[174],"evaluation":[175],"molecular":[177],"pathways":[178],"associated":[179],"proteasome":[181],"inhibition.":[182],"Results:":[183],"As":[184],"July":[186],"1,":[187],"2018,":[188],"15":[189],"treated.":[192],"median":[194,410],"age":[195],"64":[197],"years":[198],"(range,":[199],"47":[200],"81)":[202],"53%":[204],"men.":[206],"Disease":[207],"histologies":[208,527],"follicular":[210],"(FL,":[212],"n":[213,220,227,235],"=":[214,221,228,236],"10),":[215],"mantle":[216],"cell":[217],"(MCL,":[219],"2),":[222,229],"marginal":[223],"zone":[224],"(MZL,":[226],"small":[231],"lymphocytic":[232],"(SLL,":[234],"1).":[237,305],"At":[238],"start":[240],"therapy,":[242],"all":[243,331,392,452,511],"had":[244,259,421,431],"stage":[245],"III/IV":[246],"B-symptoms":[249],"40%.":[253],"For":[254],"FL,":[257,309],"80%":[258],"poor":[260],"risk":[261],"by":[262],"FLIPI.":[263],"Overall,":[264],"symptoms":[270],"due":[271,282],"(40%),":[274,464],"steady":[275],"(33%),":[279],"cytopenia":[281],"(27%).":[285],"To":[286],"date,":[287],"14":[288],"evaluable":[291],"13":[295],"experienced":[296,366],"tumor":[297,367,514],"burden":[298],"reduction":[299,368,515],"Ix-only":[302,313,428],"(Figure":[304],"Of":[306,337,384],"6":[310,332],"completed":[311,330],"and,":[316],"these,":[318,338],"5":[319],"achieved":[320,341,393,423],"PR.":[321],"An":[322],"additional":[323],"FL":[327,388,509],"have":[328,365],"not":[329,405],"monotherapy.":[336],"1":[339,351],"patient":[340,352,417],"PR":[343,425],"continues":[348],"treatment,":[350],"came":[353],"off":[354],"study":[355,541,601],"stable":[357],"cycles,":[361,382],"meeting":[370],"formal":[371,394],"criteria":[373],"continue":[375],"(after":[378],"respectively).":[383],"those":[385],"received":[390,575],"R,":[391],"remission":[395],"(3":[396],"CR,":[397],"3":[398,482],"PR).":[399],"Median":[400],"free":[402],"survival":[403],"has":[404],"been":[406],"reached":[407],"follow":[411],"up":[412],"7.4":[414],"months.":[415],"No":[416],"non-FL":[419],"histology":[420],"yet":[422],"undergone":[432],"receiving":[436],"R":[437],"time":[440],"cut.":[444],"most":[446],"common":[447],"adverse":[448],"events":[449],"(AEs)":[450],"pts":[453],"grade":[455,480,486],"1-2":[456],"nausea":[459],"(53%),":[460,462],"diarrhea":[461],"rash":[463],"fatigue":[466],"(33%).":[467],"Peripheral":[468],"neuropathy":[469],"20%":[472],"(grade":[474],"7%).":[477],"A":[478],"single":[479],"\u2265":[481],"AE":[483],"(syncope,":[485],"3).":[487],"Conclusions:":[488],"Data":[489],"from":[490],"this":[491],"interim":[492],"analysis":[493],"suggest":[494],"monotherapy":[497],"is":[498],"well":[499],"tolerated":[500],"highly":[502],"active":[503],"demonstrating":[513],"date":[517,577],"augmented":[519],"responses":[520],"following":[521],"addition":[523],"R.":[525],"Non-FL":[526],"B-NHL":[529],"appear":[530],"less":[531],"responsive":[532],"Ix,":[534],"but":[535],"numbers":[536],"small.":[538],"Accrual":[539],"continues.":[542],"Correlative":[543],"analyses":[544],"underway":[546],"determine":[548],"if":[549],"Ix-R":[552],"may":[553],"represent":[554],"viable":[556],"option":[558],"some":[560],"Figure":[564],"1.":[565],"Waterfall":[566],"plot":[567],"response.":[569],"Number":[570],"indicated":[578],"each":[580],"subject.":[581],"Four":[582],"added,":[588],"per":[589],"protocol,":[590],"cycle":[594],"ixazomib.":[596],"Asterisk":[597],"indicates":[598],"ongoing.":[602],"Disclosures":[603],"Graf:":[604],"Acerta:":[605],"Research":[606,610,613,617,621,626,630,643,651,654,665,669,672,676,679,682,687,696,700,703,706,710,713,718],"Funding;":[607,611,618,622,627,631,644,652,655,666,670,673,677,683,688,697,701,704,707,711,714],"TG":[608,663],"Therapeutics:":[609,616,664],"Beigene:":[612,653],"Funding.":[614,680,719],"Lynch:T.G.":[615],"Takeda":[619],"Pharmaceuticals:":[620],"Rhizen":[623],"Pharmaceuticals":[624],"S.A.:":[625],"Incyte":[628],"Corporation:":[629],"Johnson":[632],"Graffe":[633],"Keay":[634],"Moniz":[635],"&":[636],"Wick":[637],"LLP:":[638],"Consultancy.":[639],"Shadman:Genentech:":[640],"Consultancy;":[641,646,648,660,662,685,690,692,716],"Genentech:":[642],"Verastem:":[645],"AbbVie:":[647],"Gilead":[649],"Sciences:":[650],"Qilu":[656],"Puget":[657],"Sound":[658],"Biotherapeutics:":[659],"AstraZeneca:":[661],"Mustang":[667],"Biopharma:":[668],"Pharmacyclics:":[671],"Acerta":[674],"Pharma:":[675],"Celgene:":[678],"Gopal:Pfizer:":[681],"Aptevo:":[684],"BMS:":[686],"Brim:":[689],"Asana:":[691],"Seattle":[693],"Genetics:":[694],"Consultancy,":[695,699,709],"Gilead:":[698],"Takeda:":[702],"Merck:":[705],"Janssen:":[708],"Spectrum:":[712],"Incyte:":[715],"Teva:":[717]},"counts_by_year":[{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-25T00:00:00"}